Affordability and supply are key challenges for GLP-1 weight loss drugs but these issues are actively being addressed, notes Maurits Pot. He and Rahul Jasuja assess the market opportunity of this part of the health care space. They go over the potential side effects of weight loss drugs and the challenges companies may face.